Newsmeme!
Discover News you didn't know existed
Certain cultures around the world offer traditional diets that are not just healthy -- they also protect our bodies against disease. The secret seems to be not just in the ingredients, but in preparation and cooking styles.
Excessive summer heat can be dangerous and difficult for us humans to deal with. Imagine what it is like for animals with thick fur coats. It is interesting to see how various animals deal with high temperatures. Ears are one way animals dispel heat.
The newest revolution in microbiology testing walks on four legs and says "baa."It's the hair sheep, a less-hirsute version of the familiar woolly barnyard resident.
THE dengue season is again upon us and the Department of Health (DOH) has dutifully raised the alarm again. The warning is strangely muted. The press continues reflexively to describe the A(H1N1) virus “deadly” but no such adjective is attached to the dengue virus.
TREVOR Gillmeister, one of rugby league's toughest warriors, is shattered by the news his father Ron has an incurable asbestos-related disease.
SIMPLE changes can make a big impact on your health. Follow our quick guide to better wellbeing in 10 steps.
LARRY ELL Staff Writer LEESBURG -- Assuming Mother Nature cooperates, most people will spend much of the Fourth of July holiday outside. In Flor ...
Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study).
When left untreated, children infected with Lyme disease can experience many severe complications as a result including arthritis, problems with the heart or central nervous system. Lyme disease in children is often overlooked in its earliest stages, leading to these complications later on, according to Emma Jane MacDermott, M.D.
ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402. This follows completion of recruitment of the first cohort of 100 patients ahead of schedule.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |